The UK?s
Medicines and Healthcare products Regulatory Agency (MHRA) plans to emphasize its ?earlier access? and ?adaptive licensing? programs to spur innovation, according to an agency five-year plan. Those initiatives, intended to speed the availability ...
[Published FDA News - May 03 2013]